Published in J Surg Res on April 18, 2010
β-blockade protection of bone marrow following trauma: the role of G-CSF. J Surg Res (2011) 1.06
Does beta blockade postinjury prevent bone marrow suppression? J Trauma (2011) 1.04
The role of plasma granulocyte colony stimulating factor and bone marrow dysfunction after severe trauma. J Am Coll Surg (2012) 0.94
Does selective beta-1 blockade provide bone marrow protection after trauma/hemorrhagic shock? Surgery (2012) 0.91
Chronic restraint stress after injury and shock is associated with persistent anemia despite prolonged elevation in erythropoietin levels. J Trauma Acute Care Surg (2015) 0.89
Early propranolol administration to severely injured patients can improve bone marrow dysfunction. J Trauma Acute Care Surg (2014) 0.88
Beta Blockade Protection of Bone Marrow Following Injury: A Critical Link between Heart Rate and Immunomodulation. J Bone Marrow Res (2015) 0.82
Clonidine reduces norepinephrine and improves bone marrow function in a rodent model of lung contusion, hemorrhagic shock, and chronic stress. Surgery (2016) 0.80
Exercise as an Adjuvant Therapy for Hematopoietic Stem Cell Mobilization. Stem Cells Int (2016) 0.79
Do all β-blockers attenuate the excess hematopoietic progenitor cell mobilization from the bone marrow following trauma/hemorrhagic shock? J Trauma Acute Care Surg (2014) 0.79
Is the sympathetic system involved in shock-induced gut and lung injury? J Trauma Acute Care Surg (2012) 0.78
Exercise-induced norepinephrine decreases circulating hematopoietic stem and progenitor cell colony-forming capacity. PLoS One (2014) 0.77
β-Blockade use for Traumatic Injuries and Immunomodulation: A Review of Proposed Mechanisms and Clinical Evidence. Shock (2016) 0.75
Myelo-erythroid commitment after burn injury is under beta-adrenergic control via MafB regulation. Am J Physiol Cell Physiol (2016) 0.75
Daily propranolol administration reduces persistent injury-associated anemia following severe trauma and chronic stress. J Trauma Acute Care Surg (2017) 0.75
Effect of testosterone and hypoxia on the expansion of umbilical cord blood CD34(+) cells in vitro. Exp Ther Med (2017) 0.75
Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 4.85
Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med (2009) 1.85
Bone marrow failure following severe injury in humans. Ann Surg (2003) 1.82
Outcome after hemorrhagic shock in trauma patients. J Trauma (1998) 1.72
Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J Immunol (1990) 1.66
Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. Q J Med (1978) 1.34
PROTECTION OF FUNCTIONAL AND VASCULAR INTEGRITY OF THE SPLEEN IN TRAUMATIC SHOCK BY DENERVATION. Proc Soc Exp Biol Med (1964) 1.19
The impact of a hypercatecholamine state on erythropoiesis following severe injury and the role of IL-6. J Trauma (2005) 1.18
Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients. J Trauma (2002) 1.18
Adrenergic modulation of erythropoiesis following severe injury is mediated through bone marrow stroma. Surg Infect (Larchmt) (2004) 1.15
Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development. J Cell Physiol (1995) 1.08
Trauma inhibits erythroid burst-forming unit and granulocyte-monocyte colony-forming unit growth through the production of TGF-beta1 by bone marrow stroma. Ann Surg (2001) 1.07
The stress response of critical illness. Crit Care Clin (1999) 1.02
Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by selective alpha- and beta-adrenergic drugs in mice. J Neuroimmunol (1995) 1.01
Modulation of in vitro erythropoiesis. The influence of beta-adrenergic agonists on erythroid colony formation. J Clin Invest (1977) 1.00
Dynamic norepinephrine alterations in bone marrow: evidence of functional innervation. J Neuroimmunol (1999) 1.00
Bone marrow failure after hemorrhagic shock. Circ Shock (1990) 0.99
Adrenergic modulation of splenic macrophage cytokine release in polymicrobial sepsis. Am J Physiol Cell Physiol (2004) 0.99
Murine hematopoietic stem cells and progenitors express adrenergic receptors. J Neuroimmunol (2007) 0.95
Characterization of the beta-adrenergic receptor of the rat peritoneal macrophage. J Immunol (1985) 0.94
Transfusion practice in the critically ill. Crit Care Med (2003) 0.93
Noradrenergic and cholinergic innervation of the bone marrow. Int J Mol Med (2002) 0.90
Norepinephrine suppresses wound macrophage phagocytic efficiency through alpha- and beta-adrenoreceptor dependent pathways. Surgery (2007) 0.89
Marrow granulocyte-macrophage progenitor cell response to burn injury as modified by endotoxin and indomethacin. J Trauma (1994) 0.88
Hemorrhagic shock abolishes the myelopoietic response to turpentine-induced soft tissue injury. J Surg Res (1995) 0.86
Endocrine and molecular responses to surgical stress. Curr Probl Surg (1994) 0.86
Differential effects of acute hypoxia and endotoxin on the secretion and expression of bone marrow interleukin-1 and interleukin-6. Shock (1997) 0.86
Gut ischemia induces bone marrow failure and increases risk of infection. J Surg Res (1994) 0.86
Dose dependent reduction of erythroid progenitor cells and inappropriate erythropoietin response in exposure to lead: new aspects of anaemia induced by lead. Occup Environ Med (1999) 0.84
Measurement of catecholamines in mouse bone marrow by means of HPLC with electrochemical detection. Haematologica (1997) 0.83
Hyperadrenergic states. Crit Care Med (1991) 0.83
Mechanism of anemia associated with autonomic dysfunction in rats. Auton Neurosci (2000) 0.81
Adrenergic modulation of erythropoiesis: in vitro studies of colony-forming cells in normal and polycythaemic man. Br J Haematol (1984) 0.80
Profile of chicken macrophage functions after exposure to catecholamines in vitro. Immunopharmacol Immunotoxicol (1994) 0.79
Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res (2011) 2.31
Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol (2003) 2.21
Defining the limits of resuscitative emergency department thoracotomy: a contemporary Western Trauma Association perspective. J Trauma (2011) 1.91
Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells (2007) 1.89
Bone marrow failure following severe injury in humans. Ann Surg (2003) 1.82
Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood (2006) 1.79
Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. J Immunol (2010) 1.76
Oxygen saturation in the bone marrow of healthy volunteers. Blood (2002) 1.58
Necrotizing fasciitis and sepsis caused by Aeromonas hydrophila after crush injury of the lower extremity. Surg Infect (Larchmt) (2008) 1.52
Angiographic embolization for liver injuries: low mortality, high morbidity. J Trauma (2003) 1.48
Isolated traumatic brain injury: age is an independent predictor of mortality and early outcome. J Trauma (2002) 1.47
Prospective validation of computed tomographic screening of the thoracolumbar spine in trauma. J Trauma (2003) 1.45
The effect of age on functional outcome in mild traumatic brain injury: 6-month report of a prospective multicenter trial. J Trauma (2004) 1.41
Small volume albumin administration protects against hemorrhagic shock-induced bone marrow dysfunction. J Trauma (2004) 1.40
Changing the culture around end-of-life care in the trauma intensive care unit. J Trauma (2008) 1.38
Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity. Mol Ther Nucleic Acids (2013) 1.38
Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1 alpha. Stem Cells (2005) 1.37
Hematopoietic progenitor cells mobilize to the site of injury after trauma and hemorrhagic shock in rats. J Trauma (2007) 1.35
MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells. Proc Natl Acad Sci U S A (2007) 1.32
Immunological properties of mesenchymal stem cells and clinical implications. Arch Immunol Ther Exp (Warsz) (2008) 1.28
Distinct roles of glycogen synthase kinase (GSK)-3alpha and GSK-3beta in mediating cardiomyocyte differentiation in murine bone marrow-derived mesenchymal stem cells. J Biol Chem (2009) 1.22
Mesenchymal stem cells in early entry of breast cancer into bone marrow. PLoS One (2008) 1.22
Specification of a dopaminergic phenotype from adult human mesenchymal stem cells. Stem Cells (2007) 1.20
The role of lymph factors in lung injury, bone marrow suppression, and endothelial cell dysfunction in a primate model of trauma-hemorrhagic shock. Shock (2004) 1.18
The impact of a hypercatecholamine state on erythropoiesis following severe injury and the role of IL-6. J Trauma (2005) 1.18
Inflammatory chemoreceptor cross-talk suppresses leukotriene B4 receptor 1-mediated neutrophil calcium mobilization and chemotaxis after trauma. J Immunol (2003) 1.17
An interdisciplinary approach and characterization of neuronal cells transdifferentiated from human mesenchymal stem cells. Stem Cells Dev (2007) 1.16
Adrenergic modulation of erythropoiesis following severe injury is mediated through bone marrow stroma. Surg Infect (Larchmt) (2004) 1.15
Facilitating role of preprotachykinin-I gene in the integration of breast cancer cells within the stromal compartment of the bone marrow: a model of early cancer progression. Cancer Res (2004) 1.15
Value of repeat cranial computed axial tomography scanning in patients with minimal head injury. Am J Surg (2004) 1.11
Mobilization of bone marrow cells to the site of injury is necessary for wound healing. J Trauma (2009) 1.11
Hormonally active women tolerate shock-trauma better than do men: a prospective study of over 4000 trauma patients. Ann Surg (2007) 1.10
Management of trauma to the male external genitalia: the usefulness of American Association for the Surgery of Trauma organ injury scales. J Urol (2003) 1.07
Trauma-hemorrhagic shock mesenteric lymph from rat contains a modified form of albumin that is implicated in endothelial cell toxicity. Shock (2005) 1.06
Store-operated calcium entry in human neutrophils reflects multiple contributions from independently regulated pathways. J Immunol (2002) 1.06
β-blockade protection of bone marrow following trauma: the role of G-CSF. J Surg Res (2011) 1.06
Role of human HGFIN/nmb in breast cancer. Breast Cancer Res (2007) 1.06
Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-A peptides. Proc Natl Acad Sci U S A (2005) 1.05
RE-1-silencing transcription factor shows tumor-suppressor functions and negatively regulates the oncogenic TAC1 in breast cancer cells. Proc Natl Acad Sci U S A (2009) 1.05
Enhancing effect of IL-1alpha on neurogenesis from adult human mesenchymal stem cells: implication for inflammatory mediators in regenerative medicine. J Immunol (2007) 1.05
Impact of enhanced mobilization of bone marrow derived cells to site of injury. J Trauma (2011) 1.04
Does beta blockade postinjury prevent bone marrow suppression? J Trauma (2011) 1.04
SDF-1alpha regulation in breast cancer cells contacting bone marrow stroma is critical for normal hematopoiesis. Blood (2006) 1.03
Hematopoietic progenitor cell mobilization is mediated through beta-2 and beta-3 receptors after injury. J Trauma (2010) 1.03
Beta-blockade prevents hematopoietic progenitor cell suppression after hemorrhagic shock. Surg Infect (Larchmt) (2011) 1.02
Mesenchymal stem cells in drug/gene delivery: implications for cell therapy. Ther Deliv (2012) 1.02
Isolated thoracolumbar transverse process fractures: call physical therapy, not spine. J Trauma (2007) 1.02
Brain-derived neurotrophic factor facilitates maturation of mesenchymal stem cell-derived dopamine progenitors to functional neurons. J Neurochem (2009) 1.01
Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P. Regul Pept (2003) 1.00
Resistance of the female, as opposed to the male, intestine to I/R-mediated injury is associated with increased resistance to gut-induced distant organ injury. Shock (2008) 1.00
Tolerance-like mediated suppression by mesenchymal stem cells in patients with dust mite allergy-induced asthma. J Allergy Clin Immunol (2011) 1.00
Bone marrow stroma influences transforming growth factor-beta production in breast cancer cells to regulate c-myc activation of the preprotachykinin-I gene in breast cancer cells. Cancer Res (2004) 0.99
Tachykinins in the emerging immune system: relevance to bone marrow homeostasis and maintenance of hematopoietic stem cells. Front Biosci (2004) 0.98
A paradoxical role for IFN-gamma in the immune properties of mesenchymal stem cells during viral challenge. Exp Hematol (2005) 0.97
Role of bone marrow and mesenchymal stem cells in healing after traumatic injury. Surgery (2012) 0.96
Albumin peptide: a molecular marker for trauma/hemorrhagic-shock in rat mesenteric lymph. Peptides (2005) 0.96
A theoretical simulation of hematopoietic stem cells during oxygen fluctuations: prediction of bone marrow responses during hemorrhagic shock. Shock (2004) 0.95
Bone marrow failure in male rats following trauma/hemorrhagic shock (T/HS) is mediated by mesenteric lymph and modulated by castration. Shock (2006) 0.95
Prospective study of neutrophil chemokine responses in trauma patients at risk for pneumonia. Am J Respir Crit Care Med (2004) 0.95
G-coupled protein receptors and breast cancer progression: potential drug targets. Mini Rev Med Chem (2007) 0.94
Dopaminergic neuronal differentiation protocol for human mesenchymal stem cells. Methods Mol Biol (2011) 0.94
The role of plasma granulocyte colony stimulating factor and bone marrow dysfunction after severe trauma. J Am Coll Surg (2012) 0.94
Stromal derived growth factor-1alpha as a beacon for stem cell homing in development and injury. Curr Neurovasc Res (2005) 0.94
A novel model of dormancy for bone metastatic breast cancer cells. Cancer Res (2013) 0.93
Can mesenchymal stem cells reverse chronic stress-induced impairment of lung healing following traumatic injury? J Trauma Acute Care Surg (2015) 0.92
Attenuation of shock-induced acute lung injury by sphingosine kinase inhibition. J Trauma (2004) 0.92